SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-098861
Filing Date
2024-08-20
Accepted
2024-08-20 08:15:07
Documents
12
Period of Report
2024-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20240815.htm   iXBRL 8-K 54101
2 EX-99.1 crbp-ex99_1.htm EX-99.1 19262
  Complete submission text file 0000950170-24-098861.txt   202982

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240815.xsd EX-101.SCH 31269
14 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240815_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 241222772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)